Drug Type Small molecule drug |
Synonyms SLL-627 |
Target |
Action agonists |
Mechanism κ opioid receptor agonists(Kappa opioid receptor agonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H39NO4 |
InChIKeyKWUYBPPEGTWYTB-MOFBGKAJSA-N |
CAS Registry2765571-51-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Analgesia | Preclinical | China | 11 Aug 2022 | |
Sedation | Preclinical | China | 11 Aug 2022 |